Insider Transactions in Q3 2025 at Century Therapeutics, Inc. (IPSC)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2025
|
Chad Cowan Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
762,543
+43.45%
|
-
|
|
Sep 08
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
263
-0.06%
|
$0
$0.5 P/Share
|
|
Sep 08
2025
|
Gregory Russotti Officer |
SELL
Open market or private sale
|
Direct |
539
-0.14%
|
$0
$0.5 P/Share
|
|
Sep 08
2025
|
Brent Pfeiffenberger President and CEO |
SELL
Open market or private sale
|
Direct |
488
-0.01%
|
$0
$0.5 P/Share
|
|
Aug 14
2025
|
Brent Pfeiffenberger President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,587,614
+32.69%
|
-
|
|
Aug 04
2025
|
Douglas Carr SVP Finance & Operations |
SELL
Open market or private sale
|
Direct |
296
-0.07%
|
$0
$0.53 P/Share
|